David A. Siegel Kodiak Sciences Inc. Transaction History
Two Sigma Advisers, LP
- $42.5 Billion
- Q1 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 323,600 shares of KOD stock, worth $760,460. This represents 0.0% of its overall portfolio holdings.
Number of Shares
323,600
Previous 305,900
5.79%
Holding current value
$760,460
Previous $929,000
83.21%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding KOD
# of Institutions
112Shares Held
43MCall Options Held
87.8KPut Options Held
7.3K-
Baker Bros. Advisors LP New York, NY17.3MShares$40.7 Million1.15% of portfolio
-
Black Rock Inc. New York, NY3.86MShares$9.07 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA1.72MShares$4.05 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.65MShares$3.89 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA1.61MShares$3.79 Million0.24% of portfolio
About Kodiak Sciences Inc.
- Ticker KOD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,040,200
- Market Cap $122M
- Description
- Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...